Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.

[1]  M. Piérart,et al.  Duration of androgen suppression in the treatment of prostate cancer. , 2009, The New England journal of medicine.

[2]  J. Chapelon,et al.  Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. , 2009, European urology.

[3]  S. Fosså,et al.  Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial , 2009, The Lancet.

[4]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[5]  D. Kuban,et al.  The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. , 2007, International journal of radiation oncology, biology, physics.

[6]  A. Haese*,et al.  High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. , 2006, European urology.

[7]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[8]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Mongiat‐Artus.  Long-Term Oncologic Results of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer After Radiotherapy , 2006 .

[10]  M. Wirth,et al.  Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer , 2006, BJU international.

[11]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[12]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[13]  P. Walsh.  6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer: A Randomized Controlled Trial , 2005 .

[14]  J. Rewcastle,et al.  Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. , 2003, Clinical prostate cancer.

[15]  D. Kuban,et al.  Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. , 2002, The Journal of urology.

[16]  A. Zietman,et al.  Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Ling,et al.  Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Alexandra L Hanlon,et al.  Dose response in prostate cancer with 8-12 years' follow-up. , 2001, International journal of radiation oncology, biology, physics.

[19]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[20]  T. Tammela,et al.  Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. , 2000, The Journal of urology.

[21]  G. Perry,et al.  Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. , 2000, International journal of radiation oncology, biology, physics.

[22]  A. Bergh,et al.  After radiotherapy testosterone stimulation is unable to increase growth in the Dunning R3327-PAP prostate tumour , 1999, Urological Research.

[23]  B. Chauvet,et al.  [Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin]. , 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[24]  M. Landström,et al.  Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma. , 1997, International journal of radiation oncology, biology, physics.

[25]  S. Fosså,et al.  Prostatic carcinoma: a multivariate analysis of prognostic factors. , 1994, British Journal of Cancer.

[26]  J. Crook,et al.  Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.

[27]  F. Freiha,et al.  Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates , 1989, Cancer.

[28]  G. Andriole,et al.  Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer , 2008 .

[29]  A. Hanlon,et al.  Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[30]  Lei Dong,et al.  Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[31]  N. Vogelzang,et al.  Monitoring response, prediction methodology, staging, and imaging in prostate cancer. , 2006, Reviews in urology.

[32]  A. Fortin,et al.  Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[33]  L. Holmberg,et al.  Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy. , 1995, Acta oncologica.

[34]  J. Cox,et al.  The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. , 1977, Cancer.